Biotech

All Articles

Former Seagen chief executive officer unveils brand-new startup Ottimo Pharma

.After antibody-drug conjugate (ADC) expert Seagen was actually marketed to Pfizer last year for a t...

Ironwood produces additional purpose $1B GI medication with new subgroup data

.On the heels of a stage 3 gain that stopped working to excite financiers, Ironwood Pharmaceuticals ...

Novartis inks $150M package for autoimmune molecular glue

.Don't cease Monte Rosa Therapeutics currently. The Boston-based biotech is actually having a ball a...

Jade takes director team along with Chinook veterinarians-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of notable management hirings, shootings and als...

Septerna goes public along with upsized offering of $288M

.Celebrating his company's upsized going public (IPO), Septerna CEO Jeffrey Finer rang the position ...

AbbVie makes Richter richer, paying for $25M to constitute breakthrough pact

.AbbVie has actually come back to the resource of its own antipsychotic goliath Vraylar looking for ...

GenSight goes into ultimate weeks of money runway as revenue stream squeezes by of grasp

.GenSight Biologics is actually full weeks far from lacking cash. Again. The biotech simply possesse...

AZ licenses disposed of uncommon disease medication to Monopar Rehabs

.Monopar Therapeutics is recuperating a medicine from the scrap heap of AstraZeneca's rare disease p...

Arcus' brand new HIF-2a data in renal cancer mean prospective advantage over Merck's Welireg, analysts say

.Along with new data out on Arcus Biosciences' speculative HIF-2a prevention, one group of professio...

Roche bets around $1B to extend Dyno gene therapy distribution contract

.After creating a gene treatment alliance with Dyno Rehabs in 2020, Roche is actually back for addit...